From Medscape Diabetes & Endocrinology

Coverage from the

American Thyroid Association (ATA) 2024 Meeting

October 30 - November 03, 2024; Chicago, Illinois

October 30 - November 03, 2024 Chicago, Illinois

Conference News

ATA 2024 Examining T4/T3 Combination Therapy in Hypothyroidism
Medscape Medical News, November 21, 2024
ATA 2024 Adjusting Thyroid Ranges for Age Cuts Hypothyroidism Rates
Medscape Medical News, November 18, 2024
ATA 2024 Managing Long-Term Health Risks in Thyroid Cancer Survivors
Medscape Medical News, November 14, 2024
ATA 2024 Precautions Needed to Prevent Hematoma After Thyroid Surgery
Medscape Medical News, November 12, 2024
ATA 2024 Update Coming for Thyroid Disease in Pregnancy Guidelines
Medscape Medical News, November 8, 2024

ATA 2024 Changing Concepts in Hyperthyroidism Management
Medscape Medical News, November 7, 2024
ATA 2024 Diagnosing and Managing Thyroid Eye Disease
Medscape Medical News, November 6, 2024
ATA 2024 Pembrolizumab Boosts Survival in Anaplastic Thyroid Cancer
Medscape Medical News, November 5, 2024
ATA 2024 Batoclimab Shows Rapid Effect on Key Graves’ Disease Markers
Medscape Medical News, November 4, 2024
ATA 2024 Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Medscape Medical News, November 1, 2024

Medscape Diabetes©

Popular News From ATA 2023

Less Dairy Leads to Decline in Iodine Concentrations Iodine concentration declines among women of reproductive age in the United States over two decades correlate with reductions in dairy consumption.
Medscape Medical News, Oct 04, 2023
Nonsurgical Option for More Large Thyroid Nodule Patients? When considering all large thyroid nodules > 4 cm, false negative rates declined compared with considering only large nodules in patients that had undergone surgery, in a new analysis.
Medscape Medical News, Oct 11, 2023
Triple Therapy Boosts Anaplastic Thyroid Cancer Survival With the neoadjuvant regimen of pembrolizumab added to dabrafenib and trametinib, survival in BRAF-mutated forms of the highly aggressive cancer can go from months to more than 5 years.
Medscape Medical News, Sep 29, 2023

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.